Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study

Diabetes Care(2025)10.2337/dc25-0154Source: DataRank Database

Risk of Thyroid Tumors With GLP-1 Receptor Agonists: A Retrospective Cohort Study is a research paper published in Diabetes Care (2025). On theSindex it has a DataRank of 0. It has been cited 16 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access16 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 11.38)OA: bronzeTopics (36)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (31)

Fan Bu ORCID,Benjamin Viernes ORCID,Scott L. DuVall ORCID,Michael E. Matheny ORCID,Katherine Simon ORCID

Live enrichment

PubMed:40465422 OpenAlex:https://openalex.org/W4411020975

US Department of Veterans Affairs

Grant: ORD 22-D4V

National Institutes of Health

Grant: K23 HL153775

National Institutes of Health

Grant: R01 HG006139

National Institutes of Health

Grant: R01 HL169954

National Institutes of Health

Grant: R01 LM006910

FWCI

11.38

Citation Percentile

1.0%

Citation Trend

2025

2026

bronzeLicense: https://www.diabetesjournals.org/journals/pages/license

journalhttps://diabetesjournals.org/care/article-pdf/doi/10.2337/dc25-0154/819987/dc250154.pdf

publisherhttps://diabetesjournals.org/care/article-pdf/doi/10.2337/dc25-0154/819987/dc250154.pdf

publisherhttps://diabetesjournals.org/care/article-pdf/48/8/1386/819987/dc250154.pdf

journalhttps://doi.org/10.2337/dc25-0154

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40465422

Fields of Study

Diabetes Treatment and ManagementNeuroendocrine Tumor Research AdvancesMetabolism, Diabetes, and Cancer

MeSH Terms

Sodium-Glucose Transporter 2 InhibitorsGlucagon-Like Peptide-1 Receptor AgonistsAgedDiabetes Mellitus, Type 2FemaleHumansHypoglycemic AgentsMaleMiddle AgedRetrospective StudiesThyroid NeoplasmsDipeptidyl-Peptidase IV Inhibitors

Keywords

MedicineHazard ratioPropensity score matchingInternal medicineGlucagon-like peptide 1 receptorRetrospective cohort studyLiraglutideThyroid cancerDipeptidyl peptidase-4Proportional hazards modelType 2 diabetesCohortCohort studyConfoundingOncologyThyroidDiabetes mellitusEndocrinologyConfidence intervalAgonistReceptor

Sustainable Development Goals

SDG 0: Good health and well-being